FAG
CRSP icon

Fortitude Advisory Group’s CRISPR Therapeutics CRSP Stock Holding History

Fortitude Advisory Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51
Closed -$3K – 427
2022
Q1 		$3K Sell
51
-100
-66% -$5.88K ﹤0.01% 1246
2021
Q4 		$12K Buy
+151
New +$12K 0.01% 971